Tradestie Institutional Equity Comparison Engine

ENTX vs KTTA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ENTX Overall Edge

ENTX Captures Institutional Edge (2โ€“0 Pillars ยท 5โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Entera Bio Ltd. Ordinary Shares (ENTX) driven by superior Momentum & Technical, Options & Structure. Fundamentally, ENTX trades at N/M Forward P/E with 0.0% operating margin (-100.0% YoY revenue) versus KTTA at N/M Forward P/E and 0.0% operating margin (+1498.1% YoY). In options structure, ENTX sits in CONSOLIDATION (33rd %ile IV; Dealer Gamma Walls on Pro) against KTTA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ENTX N/M vs KTTA N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin 0.0% vs 0.0% ยท YoY -100.0% vs +1498.1%
Momentum & Technical Winner ENTX
1Y +24.7% vs +0.6% ยท 52W Pos 73% vs 11%
Options & Structure Winner ENTX
CONSOLIDATION (33rd %ile IV) vs UNCLASSIFIED (N/A IV)
ENTX NASDAQ
Entera Bio Ltd. Ordinary Shares
Biological Products, (No Disgnostic Substances)
$3.31
+0.76% 1D
Market Cap $571.2M
1M Return +9.44%
1Y Return +24.72%
Forward P/E N/M
Unified AI Score
47.5 / 100 HOLD
Tech 52.0 Fund 49.0 Flow 72.0 Mom 50.0
KTTA NASDAQ
Pasithea Therapeutics Corp. Common Stock
Pharmaceutical Preparations
$0.48
-0.48% 1D
Market Cap $17.7M
1M Return +7.52%
1Y Return +0.59%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 20.0 Fund 40.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ENTX +24.72% KTTA +0.59% Spread: +24.13 pp (ENTX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ENTX Revenue KTTA Revenue ENTX Op. Margin KTTA Op. Margin Margin Edge
FY2020 $0M N/A -3059.7% N/A ENTX
FY2021 $0M $0M -2139.6% -29925.7% ENTX
FY2022 $0M $0M -9714.2% -2587.3% KTTA
FY2024 $0M N/A -5295.6% N/A ENTX
FY2025 $0M N/A -27450.0% N/A ENTX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ENTX (5) vs KTTA (1)
Institutional Metric ENTX KTTA Criterion Row Winner
Market Capitalization Scale $571.2M $17.7M Larger Scale ENTX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -100.0% +1498.1% Higher Growth KTTA
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -20.3% -88.8% Higher ROE ENTX
52-Week Range Position Momentum 73% ($1โ€“$4) 11% ($0โ€“$2) Stronger Trend ENTX
Beta / 30D Volatility Risk Regime 0.92ฮฒ ยท 53% Vol 0.68ฮฒ ยท 185% Vol Lower Realized Risk ENTX
Unified Institutional Score Composite Signal 47.5 / 100 (HOLD) 42.1 / 100 (HOLD) Higher Composite ENTX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ENTX vs KTTA Buy Guide
ENTX CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 33rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ENTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KTTA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KTTA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ENTX nor KTTA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.